Suki, a leader in AI technology for healthcare, announced $70 million in new funding, bringing its total to $165 million. The funding, led by Hedosophia and supported by Venrock and other investors, will help Suki expand its leadership team, accelerate product development, and strengthen commercial initiatives. Key partnerships with leading health systems like MedStar Health, along with collaborations with major electronic health record (EHR) providers such as Epic, Oracle Cerner, and MEDITECH, underscore Suki’s growing influence.
Suki’s flagship product, Suki Assistant, uses AI to streamline clinicians' administrative tasks, such as documentation, coding, and clinical queries, improving efficiency by up to 72%. This has led to a high adoption rate among health systems and hospitals, with Suki helping clinicians complete notes faster, improve documentation quality, and enhance revenue capture. Suki also offers Suki Platform, a suite of developer tools that powers AI voice experiences in partner solutions across the healthcare industry.
The new investment will fuel the expansion of Suki’s product offerings, with plans to enhance the capabilities of Suki Assistant and Suki Platform. As healthcare systems seek innovative AI solutions to reduce clinician burnout and improve patient care, Suki’s advanced EHR integration and flexibility make it a valuable partner. The company’s deep collaborations continue to impact clinician well-being and elevate the standard of care across specialties and settings.
Click here to read the original news story.